Over the last 7 days, the Pharma industry has dropped 2.6%, driven by a pullback from Neuren Pharmaceuticals of 4.7%. Meanwhile, Clarity Pharmaceuticals actually outperformed within the industry, gaining 11% in the last week. However, the industry is down 5.0% over the past year. As for the next few years, earnings are expected to grow by 31% per annum.
Has the Australian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 01 Jun 2023 | AU$4.1b | AU$993.2m | -AU$640,306,659.00 | 18.8x | -6.3x | 4.1x |
Sat, 29 Apr 2023 | AU$4.3b | AU$993.2m | -AU$641,969,868.00 | 20.5x | -6.7x | 4.3x |
Mon, 27 Mar 2023 | AU$4.0b | AU$995.9m | -AU$648,651,745.00 | 18.2x | -6.2x | 4.1x |
Wed, 22 Feb 2023 | AU$3.6b | AU$981.5m | -AU$594,318,566.00 | 16.6x | -6x | 3.6x |
Fri, 20 Jan 2023 | AU$3.7b | AU$948.3m | -AU$544,428,006.00 | 13x | -6.9x | 3.9x |
Sun, 18 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.3x | -7.1x | 4.1x |
Tue, 15 Nov 2022 | AU$4.3b | AU$948.3m | -AU$544,428,005.00 | 13.2x | -7.9x | 4.5x |
Thu, 13 Oct 2022 | AU$4.2b | AU$882.1m | -AU$556,645,005.00 | 12.2x | -7.5x | 4.7x |
Sat, 10 Sep 2022 | AU$4.2b | AU$943.4m | -AU$537,548,829.00 | 12.7x | -7.8x | 4.4x |
Mon, 08 Aug 2022 | AU$3.9b | AU$819.9m | -AU$339,669,589.00 | 15.6x | -11.6x | 4.8x |
Wed, 06 Jul 2022 | AU$3.4b | AU$818.2m | -AU$353,932,589.00 | 13.2x | -9.5x | 4.1x |
Fri, 03 Jun 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 14.8x | -11.1x | 4.8x |
Sun, 01 May 2022 | AU$4.1b | AU$800.9m | -AU$348,637,558.00 | 15.7x | -11.7x | 5.1x |
Tue, 29 Mar 2022 | AU$4.2b | AU$799.2m | -AU$341,805,125.00 | 18.1x | -12.4x | 5.3x |
Thu, 24 Feb 2022 | AU$4.4b | AU$743.6m | -AU$460,156,833.00 | 19.9x | -9.6x | 5.9x |
Sat, 22 Jan 2022 | AU$4.8b | AU$758.4m | -AU$450,516,414.00 | 20.6x | -10.6x | 6.3x |
Mon, 20 Dec 2021 | AU$4.8b | AU$758.4m | -AU$450,516,414.00 | 23.7x | -10.5x | 6.3x |
Wed, 17 Nov 2021 | AU$4.9b | AU$758.4m | -AU$447,307,205.00 | 24.1x | -11x | 6.5x |
Fri, 15 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.5x | -10.6x | 6.3x |
Sun, 12 Sep 2021 | AU$4.8b | AU$753.9m | -AU$445,060,581.00 | 21.9x | -10.7x | 6.3x |
Tue, 10 Aug 2021 | AU$4.1b | AU$752.8m | -AU$442,004,016.00 | 21.3x | -9.3x | 5.4x |
Mon, 03 May 2021 | AU$4.8b | AU$758.7m | -AU$449,177,839.00 | 12.3x | -10.6x | 6.3x |
Thu, 04 Feb 2021 | AU$4.5b | AU$759.6m | -AU$478,696,362.00 | 75.2x | -9.5x | 6x |
Sun, 08 Nov 2020 | AU$3.7b | AU$761.5m | -AU$402,127,165.00 | 21.2x | -9.2x | 4.9x |
Sat, 01 Aug 2020 | AU$3.7b | AU$773.8m | -AU$314,501,632.00 | 40.2x | -11.9x | 4.8x |
-10x
How does Australian Pharma compare with similar industries?
AU Market | -1.60% | |
Healthcare | 0.068% | |
Pharma | 0.55% | |
Pharma | 0.55% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
NEU Neuren Pharmaceuticals | AU$14.15 | 2.5% +AU$44.3m | 269.5% | PE9733.2x | |
VIT Vitura Health | AU$0.34 | 9.5% +AU$16.7m | 32.7% | PE18.6x | |
ZLD Zelira Therapeutics | AU$2.30 | 155.6% +AU$15.9m | 94.9% | PS29.3x | |
MYX Mayne Pharma Group | AU$3.77 | 5.3% +AU$15.5m | -37.2% | PS0.9x | |
MVP Medical Developments International | AU$0.82 | 13.0% +AU$8.2m | -67.4% | PS1.6x |